(Total Views: 310)
Posted On: 05/23/2019 2:16:14 PM
Post# of 89337
$DECN $JNJ
DECN to Discuss Three Major Events After Memorial Day Holiday Company Plans to Communicate 3rd Offer for the Monitizing Its New "TBG" Products, Developments in Big Box Efforts And the J&J Litigation
LOS ANGELES, CA - May 23, 2019 - Decision Diagnostics Corp. (OTC: DECN) – Keith Berman CEO of the FDA registered 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, etc is announcing that beginning next week we will discuss the following issues in detail, Read More. See Complete Information: http://www.thestreetnow.com/spotlight/dailynews/
DECN to Discuss Three Major Events After Memorial Day Holiday Company Plans to Communicate 3rd Offer for the Monitizing Its New "TBG" Products, Developments in Big Box Efforts And the J&J Litigation
LOS ANGELES, CA - May 23, 2019 - Decision Diagnostics Corp. (OTC: DECN) – Keith Berman CEO of the FDA registered 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, etc is announcing that beginning next week we will discuss the following issues in detail, Read More. See Complete Information: http://www.thestreetnow.com/spotlight/dailynews/
(0)
(0)
